Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1 19-Reference-Cited by-同舟云学术

Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1 19

Published:2017-04 Issue:18 Volume:35 Page:2463-2472
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Rocha Mariana Vilela,Françoso Kátia Sanches,Lima Luciana Chagas,Camargo Tarsila Mendes,Machado Ricardo L.D.,Costa Fabio T.M.,Rénia Laurent,Nosten Francois,Russell Bruce,Rodrigues Mauricio M.,Soares Irene S.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Instituto Nacional de Ciência e Tecnologia de Vacinas

Fundação de Amparo à Pesquisa do Estado de São Paulo

FAPESP

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children;Olotu;N Engl J Med,2016

2. Plasmodium vivax malaria vaccines: why are we where we are?;Reyes-Sandoval;Hum Vaccin Immunother,2013

3. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature;Lacerda;Malar J,2012

4. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900;Rahimi;Malar J,2014

5. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis;Price;Lancet Infect Dis,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and serological responses to a novel Plasmodium vivax merozoite surface protein 1 (PvMSP-1) derived synthetic peptide: a putative biomarker for malaria exposure;PeerJ;2024-06-25

2. Challenges and Opportunities in the Process Development of Chimeric Vaccines;Vaccines;2023-12-08

3. Construction, Expression, and Evaluation of the Naturally Acquired Humoral Immune Response against Plasmodium vivax RMC-1, a Multistage Chimeric Protein;International Journal of Molecular Sciences;2023-07-18

4. Plasmodium vivax vaccine: What is the best way to go?;Frontiers in Immunology;2023-01-16

5. New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates;PLOS ONE;2021-11-02